Edition:
United States

Lannett Company Inc (LCI)

LCI on New York Consolidated

22.30USD
21 Feb 2017
Change (% chg)

$-0.10 (-0.45%)
Prev Close
$22.40
Open
$22.45
Day's High
$22.75
Day's Low
$22.20
Volume
189,971
Avg. Vol
1,187,847
52-wk High
$39.99
52-wk Low
$16.75

Summary

Name Age Since Current Position

Jeffrey Farber

55 2012 Chairman of the Board

Arthur Bedrosian

69 2014 Chief Executive Officer, Director

Martin Galvan

63 2012 Chief Financial Officer, Vice President - Finance, Treasurer

Kristie Stephens

2016 Chief Compliance Officer, Vice President

Robert Ehlinger

58 2011 Vice President - Logistics, Chief Information Officer

Kevin Smith

55 2002 Vice President - Sales and Marketing

John Abt

50 2015 Vice President of Quality

Rohit Desai

74 2015 Vice President of New Product Strategy

John Kozlowski

2016 Vice President Financial Operations and Corporate Controller

Albert Paonessa

55 2015 Director

David Drabik

47 2011 Independent Director

James Maher

63 2013 Independent Director

Paul Taveira

56 2012 Independent Director

Biographies

Name Description

Jeffrey Farber

Mr. Jeffrey Farber is Chairman of the Board of LANNETT COMPANY, INC.. Mr. Farber was elected a Director of the Company in May 2006 and was appointed Chairman of the Board of Directors in July 2012. Jeffrey Farber joined the Company in August 2003 as Secretary. Since 1994, Mr. Farber has been President and the owner of Auburn Pharmaceutical (“Auburn”), a national generic pharmaceutical distributor. Prior to starting Auburn, Mr. Farber served in various positions at Major Pharmaceutical (“Major”), where he was employed for over 15 years. At Major, Mr. Farber was involved in sales, purchasing and eventually served as President of the mid-west division. Mr. Farber also spent time working at Major’s manufacturing division — Vitarine Pharmaceuticals — where he served on its Board of Directors. Mr. Farber graduated from Western Michigan University with a Bachelor of Science Degree in Business Administration and participated in the Pharmacy Management Graduate Program at Long Island University.

Arthur Bedrosian

Mr. Arthur P. Bedrosian, J.D., is the Chief Executive Officer, Director of Lannett Company, Inc. He was promoted to President of the Company in May 2002 and CEO in January of 2006. Previously, he served as the Company’s Vice President of Business Development from January 2002 to April 2002. Mr. Bedrosian was elected as a Director in February 2000 and served to January 2002. Mr. Bedrosian was re-elected a Director in January 2006. Mr. Bedrosian has operated generic drug manufacturing, sales, and marketing businesses in the healthcare industry for many years. Prior to joining the Company, from 1999 to 2001, Mr. Bedrosian served as President and Chief Executive Officer of Trinity Laboratories, Inc., a medical device and drug manufacturer. Mr. Bedrosian also operated Pharmaceutical Ventures Ltd, a healthcare consultancy, Pharmeral, Inc. a drug representation company selling generic drugs, and Interal Corporation, a computer consultancy to Fortune 100 companies. Mr. Bedrosian holds a Bachelor of Arts Degree in Political Science from Queens College of the City University of New York and a Juris Doctorate from Newport University in California.

Martin Galvan

Mr. Martin P. Galvan, CPA, is Chief Financial Officer, Vice President - Finance, Treasurer of Lannett Company, Inc. Most recently, he was Chief Financial Officer of CardioNet, Inc., a medical technology and service company. From 2001 to 2007, Most recently, he was Chief Financial Officer of CardioNet, Inc., a medical technology and service company. From 2001 to 2007, Mr. Galvan was employed by Viasys Healthcare Inc., a healthcare technology company that was acquired by Cardinal Health, Inc. in June 2007. Prior to the acquisition, he served as Executive Vice President, Chief Financial Officer and Director Investor Relations. From 1999 to 2001, Mr. Galvan served as Chief Financial Officer of Rodel, Inc., a precision surface technologies company in the semiconductor industry. From 1979 to 1998, Mr. Galvan held several positions with Rhone-Poulenc Rorer Inc., a pharmaceutical company, including Vice President, Finance — The Americas; President & General Manager, RPR Mexico & Central America; Vice President, Finance, Europe/Asia Pacific; and Chief Financial Officer, United Kingdom & Ireland. Mr. Galvan began his career with the international accounting firm Ernst & Young LLP. He earned a Bachelor of Arts degree in economics from Rutgers University and is a member of the American Institute of Certified Public Accountants.

Kristie Stephens

Ms. Kristie Stephens is Vice President Regulatory Affairs and Chief Compliance Officer of the Company. She is responsible for ensuring regulatory compliance, engaging in effective dialogue with all U.S. regulatory bodies and overseeing the company's clinical and regulatory affairs. Prior to the promotion, Stephens served as Lannett's director of regulatory affairs. She first joined the company in 1999 as a chemist. Over her 16-year tenure, Stephens rose through the ranks of the company's regulatory department. She led the company's regulatory affairs efforts during the due diligence process of two recent acquisitions; and, afterward, was responsible for integrating the regulatory affairs staff from three sites to establish one corporate group. Stephens earned a bachelor of science degree in biology from Millersville University of Pennsylvaniaand a master of science degree in quality assurance and regulatory affairs from Temple University.

Robert Ehlinger

Mr. Robert Ehlinger is Vice President - Logistics, Chief Information Officer of Lannett Company, Inc. In June 2011, Mr. Ehlinger joined the Company in July 2006 as Chief Information Officer. In June 2011, Mr. Ehlinger was promoted to Vice President of Logistics and Chief Information Officer. Prior to joining Lannett, Mr. Ehlinger was the Vice President of Information Technology at MedQuist, Inc., a healthcare services provider, where his career spanned 10 years in progressive operational and technology roles. Prior to MedQuist, Mr. Ehlinger was with Kennedy Health Systems as their Corporate Director of Information Technology supporting acute care and ambulatory care health information systems and biomedical support services. Earlier on, Mr. Ehlinger was with Dowty Communications where he held various technical and operational support roles prior to assuming the role of International Distribution Sales Executive managing the Latin America sales distribution channels. Mr. Ehlinger received a Bachelor’s of Arts degree in Physics from Gettysburg College in Gettysburg, PA.

Kevin Smith

Mr. Kevin R. Smith is Vice President - Sales and Marketing of Lannett Company, Inc. Mr. Smith joined the Company in January 2002 as Vice President of Sales and Marketing. Prior to this, from 2000 to 2001, he served as Director of National Accounts for Bi-Coastal Pharmaceutical, Inc., a pharmaceutical sales representation company. Prior to this, from 1999 to 2000, he served as National Accounts Manager for Mova Laboratories Inc., a pharmaceutical manufacturer. Prior to this, from 1991 to 1999, Mr. Smith served as National Sales Manager at Sidmak Laboratories, a pharmaceutical manufacturer. Mr. Smith has extensive experience in the generic sales market, and brings to the Company a vast network of customers, including retail chain pharmacies, wholesale distributors, mail-order wholesalers and generic distributors. Mr. Smith has a Bachelor of Science Degree in Business Administration from Gettysburg College.

John Abt

Mr. John M. Abt is Vice President of Quality of the LANNETT COMPANY, INC. Mr. Abt joined the Company in March 2015 as Vice President of Quality. Prior to joining the Company, Mr. Abt held senior level positons in both quality and operations and has extensive knowledge in pharmaceutical manufacturing, quality, strategy, business improvement and site transformation. He most recently served as Teva Pharmaceuticals’ Vice President Global Quality Strategy, overseeing the development and implementation of strategy and associated initiatives for the global quality organization. Before that, he held a number of leadership positions of increasing responsibility in operations, continuous improvement, quality systems and compliance. He earned his Masters of Administrative Science in Business Management from John Hopkins University and a Bachelor of Science in Biochemistry from Niagara University.

Rohit Desai

Mr. Rohit Desai is Vice President of New Product Strategy of LANNETT COMPANY, INC. Mr. Desai joined the Company as Vice President of New Product Strategy in June 2015. Prior to joining the Company, Mr. Desai was the President/CEO and Co-Founder of Silarx Pharmaceuticals’, founded in 1986. Mr. Desai has over forty years of experience in research and development to commercialization in the pharmaceutical industry. Prior to founding Silarx Pharmaceuticals, Mr. Desai worked in research and development with Revlon Healthcare Group, designing and synthesizing new drugs, drug discovery and analytical method development. He earned a M.S. in Medicinal Chemistry from the University of Montana and a BS Chemistry from the University of Bombay, India.

John Kozlowski

Mr. John Kozlowski is Vice President Financial Operations and Corporate Controller of the Company. He joined Lannett in 2009, most recently serving as corporate controller. In his expanded role, he will be responsible for directing the company's accounting activities to ensure accurate and timely compliance with all internal and external requirements, and driving efficiencies and standardization throughout the accounting function to enhance the monthly close, consolidations, controls and reporting processes. In addition, he will lead the company's financial planning, and budget management and analysis, and collaborate with senior leadership on the development of the company's business plans. Prior to joining Lannett, Kozlowski served in senior finance and accounting roles for Optium Corporation and Finisar Australia. Kozlowski earned a bachelor of arts degree in finance from James Madison University and a master of business administration degree from Rider University.

Albert Paonessa

Mr. Albert Paonessa, III is a Director of the LANNETT COMPANY, INC. effective July 1, 2015. Mr. Paonessa retired from Anda, Inc., the fourth largest distributor of generic drugs in the U.S, in January 2015 after serving as President for the past 10 years. He previously served as Anda’s Senior Vice President of Sales and before that as Vice President of IT. Earlier, Mr. Paonessa was Vice President of Operations for VIP Pharmaceuticals, which was acquired by Anda’s parent company, Andrx, in 2000. Mr. Paonessa earned a Bachelor of Arts degree in Interpersonal Communications from Bowling Green State University.

David Drabik

Mr. David Drabik is an Independent Director of Lannett Company, Inc. Mr. Drabik is a National Association of Corporate Directors Governance Fellow. Since 2002, Mr. Drabik has been President of Cranbrook & Co., LLC (“Cranbrook”), an advisory firm primarily serving the private equity and venture capital community. At Cranbrook, Mr. Drabik assists and advises its clientele on originating, structuring, and executing private equity and venture capital transactions. From 1995 to 2002, Mr. Drabik served in various roles and positions with UBS Capital Americas (and its predecessor UBS Capital LLC), a New York City based private equity and venture capital firm that managed $1.5 billion of capital. From 1992 to 1995, Mr. Drabik was a banker with Union Bank of Switzerland’s Corporate and Institutional Banking division in New York City. Mr. Drabik graduated from the University of Michigan with a bachelor’s degree in Business Administration.

James Maher

Mr. James M. Maher is an Independent Director of Lannett Company, Inc. He was appointed as a Director of the Company in June 2013. He spent his entire 37 year professional career with PricewaterhouseCoopers (PwC) LLP, including 27 years as a partner, before retiring in June 2012. Most recently, Maher served as the managing partner of PwC’s U.S. assurance practice, comprised of more than 1,100 partners and 12,000 staff. Previously, he served as the regional assurance leader for the metro assurance practice. During his tenure at PwC, Maher worked closely with senior management at several multinational companies, dealing extensively with significant acquisitions, divestitures, initial public offerings and secondary offerings. Maher earned a bachelor’s degree in Accounting from LIU Post.

Paul Taveira

Mr. Paul Taveira is an Independent Director of Lannett Company, Inc. Mr. Taveira has been Chief Executive Officer of A&D Environmental Services Inc., an environmental and industrial services company, since 2009. He currently serves on their Board of Directors. From 2007 to 2009, Mr. Taveira was a Managing Partner of Precision Source LLC, a manufacturer of precision parts for various industries across the United States. From 1997 to 2007, Mr. Taveira held several positions at PSC Inc., a national provider of environmental services, including President, Vice President and Regional General Manager. From 1987 to 1997, Mr. Taveira held several management positions with Clean Harbors Inc., an international provider of environmental and energy services. Mr. Taveira graduated from Worcester State University with a Bachelor of Science degree in Biology.